NEWS
Primary Care Doctors Are Left Out of the Vaccine Rollout
In the rush to immunize people against Covid, federal and state health officials have overlooked the role of doctors, physicians say. Primary care doctors have grown increasingly frustrated with their exclusion from the nation’s vaccine rollout, unable to find...
Researchers Study Virus Evolution Trends Relevant for COVID-19 and Other Pandemics
One year after the first COVID-19 case was reported, researchers and medical professionals continue to learn more about the virus that causes it. Through a $188,253 National Science Foundation grant, Rutgers University‒Camden researcher Andrey Grigoriev is studying...
Research Team Studying Aging and Disease Adapts During Pandemic
After decades of investigating the molecular mysteries behind aging and disease, Monica Driscoll last spring faced a puzzling new problem. How would her team of nearly two dozen researchers – comprising one of Rutgers University’s largest and most prominent science...
Rutgers’ Dr. Rey Panettieri on the Johnson and Johnson vaccine
Dr. Rey Panettieri, Rutgers professor of medicine, joins ‘Power Lunch’ to discuss the vaccine options out there and the state of the vaccination rollout. To watch the full interview.
Adherence to health precautions, not climate, the biggest factor driving wintertime COVID-19 outbreaks
The researchers — working in summer 2020 — ran simulations of a wintertime coronavirus outbreak in New York City to identify key factors that would allow the virus to proliferate. They found that relaxing control measures in the summer months led to an outbreak in the...
Community Health Workers, Often Overlooked, Bring Trust to the Pandemic Fight
As the pandemic brings long-standing health disparities into sharper view, community health workers are coming to the forefront in the public health response. Read the Full Article.
Here’s where all the COVID-19 vaccine candidates currently stand
There are currently more than 150 different COVID-19 vaccines under development. Of these, more than 50 have reached human trials, and several have been approved for emergency or full use on six continents. In the US, two vaccines—one from the biotechnology company,...
Addressing Structural Racism to Improve Health
The National Institutes of Health (NIH) is taking a hard look at what it’s doing and how it can be done differently so as to no longer perpetuate the status quo. According to NIH Director, Office of Behavioral and Social Sciences Research William T. Riley, PhD:...